about
Nutritional Vitamin D in Renal Transplant Patients: Speculations and Reality.The A736V TMPRSS6 polymorphism influences hepcidin and iron metabolism in chronic hemodialysis patients: TMPRSS6 and hepcidin in hemodialysis.Protective effects of genetic inhibition of Discoidin Domain Receptor 1 in experimental renal diseaseDiscoidin domain receptor-1 and periostin: new players in chronic kidney diseaseCalcium and osteoprotegerin levels predict the progression of the abdominal aortic calcifications after kidney transplantation.Calcium and phosphate control by dialysis treatments.Recent insights into vitamin D and its receptor.Vitamin D and the cardiovascular system: an overview of the recent literature.Current indications to parathyroidectomy in CKD patients before and after renal transplantation.Metabolic acidosis in renal transplantation: neglected but of potential clinical relevance.FGF23-regulated production of Fetuin-A (AHSG) in osteocytes.ADPKD: clinical issues before and after renal transplantation.New immunoassays for total, IgA and IgM antibodies against hepatitis E virus: Prevalence in Italian blood donors and patients with chronic liver or kidney diseases.Authors' reply to the comments on the paper: "FGF23-regulated production of Fetuin A (AHSG) in osteocytes".FGF23 and Fetuin-A Interaction in the Liver and in the Circulation.Long-term evaluation of coronary artery calcifications in kidney transplanted patients: a follow up of 5 yearsFGF23 and Fetuin-A Interaction and Mesenchymal Osteogenic TransformationCinacalcet: pharmacological and clinical aspectsTargeting connexin 43 protects against the progression of experimental chronic kidney disease in miceNeuroD Expression in Podocytes and Interrelationships with Nephrin at Both Nuclear and Cytoplasmic SitesCorrigendum to FGF23-regulated production of fetuin-A (AHSG) in osteocytes [Bone 83 (2016) 35-47]Impact of hepatitis C virus and direct acting antivirals on kidney recipients: a retrospective studyNovel markers of graft outcome in a cohort of kidney transplanted patients: a cohort observational studySecondary and Tertiary HyperparathyroidismUremic Patients with Increased Vascular Calcification Score Have Serum with High Calcific Potential: Role of Vascular Smooth Muscle Cell Osteoblastic Differentiation and ApoptosisThe Importance of Adherence in the Treatment of Secondary HyperparathyroidismMicrowave Ablation of Renal Cell Carcinoma of the Transplanted Kidney: Two CasesNative Hypovitaminosis D in CKD Patients: From Experimental Evidence to Clinical Practice
P50
Q33851824-73F18774-6AEB-4839-88C4-78387866C607Q34596298-EBFD4E80-D46A-4ECD-9287-D5BCE426E6B5Q36583215-B213B701-6A87-4D6D-8EDA-7E2C6A2C1162Q36801573-A5653410-E24C-4A56-B57D-0FBBE06C6FF4Q37020312-9431849D-4E09-4056-B327-0F90044C4FC4Q37417305-A1458AA6-C83F-4CF2-828E-C5CCEAC619ECQ37881937-B074BF34-ADCE-42DE-8EAA-5D5F48327FECQ38152318-FE20F75F-C48A-44B4-B256-5C1EC444E9F8Q38166898-15C3A09C-1632-40EF-9526-54486D1F7726Q38454884-5360DFF6-D5A5-4519-BEF0-105AEB40BA8CQ38952487-A614FECE-CCDC-4E73-8ADF-A8443389EC67Q38987102-4E2DC508-5B2B-4292-9256-6814F0E8BD16Q39952582-883125A4-FBCA-4D73-839D-F293AA2C910AQ51622119-961A1D38-85A3-425A-A557-3B8E52429980Q55284324-15CEF38A-914F-45D9-8FDE-B8FE1B836092Q64069283-247A322B-54F5-4AB5-9561-CD53ADC53461Q64256952-553A0252-20C5-4DC4-BA06-3DD1AB861037Q82758197-C12651CC-EDF0-4D4D-AF68-9DEF5EC7CCB3Q87924484-3C794214-F2C5-479B-8C4F-5D36456F1147Q88399425-B80399E4-F95C-4F46-8C82-67C1CF72E74FQ88611042-60BC706E-F4F0-4626-92AD-E5516679DCE0Q90723801-525ECFB7-A9E4-48ED-A97B-67EB0B07CE12Q90975796-F898BDD0-D869-4636-B4A1-722A29665321Q91039175-9AC97FAE-5313-4ADB-BB17-64D9F49EB8DDQ91380569-87D151FC-5DD0-4187-B5C2-859578A11283Q91485812-4153D4C4-9B7E-4911-9243-F352EA373962Q92464458-8D3EAABA-6B2A-4AA0-91D2-F05A488691A2Q92824059-2AB95B28-113F-4AB1-9FBA-4527EFF91AC7
P50
description
researcher ORCID ID = 0000-0003-3860-5219
@en
wetenschapper
@nl
name
Carlo M Alfieri
@ast
Carlo M Alfieri
@en
Carlo M Alfieri
@nl
type
label
Carlo M Alfieri
@ast
Carlo M Alfieri
@en
Carlo M Alfieri
@nl
prefLabel
Carlo M Alfieri
@ast
Carlo M Alfieri
@en
Carlo M Alfieri
@nl
P31
P496
0000-0003-3860-5219